Concierge Medicine Market Size and Share Analysis by Application (Primary Care, Pediatrics, Osteopathy, Internal Medicine, Cardiology, Psychiatry), Ownership (Independent, Group), End User (Adults, Children)

Description

Market Overview

The global concierge medicine market is around USD 17.1 billion. However, this figure is estimated to rise to USD 27.6 billion by 2030, which is equivalent to a 7.3% compound annual growth rate from 2024 to 2030.

This development of the industry can be credited to the increasing knowledge about initial disease diagnosis, the growing elderly populace, and the increasing efforts of individuals to attain a healthy and balanced lifestyle. Moreover, the benefits provided by concierge medicine comprise high recompenses for doctors and reduced waiting times for patients, which make this method common among both.

With the increasing use of telemedicine and tele health, the market picked up. Patients who have availed of concierge medicine services appreciate these technologies as they can schedule consultations with the physician as and when convenient. On the other hand, it replaces traveling that a patient would take to the doctor 's office.

This helps save patients time and money. Telemedicine applications provide high-resolution audio and video teleconferences, which enable easy access for patients to the physician from the comfort of their homes.

In addition to that, providers can manage the number of patients not showing up, since telemedicine could be utilized for this purpose. Thus, the convenience offered by such technologies has a positive impact on patient flow and increases the doctor's revenue.

Key Insights

In 2023, the primary care category grips the largest industry share because of augmented patient awareness, offering instant access to doctors and advanced-quality medicinal services.

For the patients the main advantage of primary care is that they receive longer, more comprehensive consultations, and get used to this setting, with the high patient volumes, to keep pace.

Concierge medicine is gaining popularity among high earners due to personalized healthcare services and the shortage of healthcare providers.

Paediatrics is projected to have the highest CAGR rate of 7.8% during the forecast period because pediatricians will have more time to treat each patient, especially neonates, infants, and toddlers who require targeted diagnosis and treatment.

In 2023, the group category dominates the industry with a share of approximately 60%.

The substantial existence of several top firms in the market offering these services is the major factor propelling the market.

Independent ownership in concierge medication is projected to advance quickly over the forecast period.

Independent practitioners see fewer patients every day in comparison to regular and group ownership models, leading to less workload, better compensation, and job satisfaction.

Rising awareness regarding physical well-being and the accuracy of healthcare boosts industry development.

Well-established healthcare infrastructure and favourable medical reimbursement policies contribute significantly to the region's dominance.

The global increase in the range of diseases of duration such as cancer, hyperglycaemia, and obesity is an issue that facilitates the development of precision medicine solutions.

The presence of a significant elderly population drives demand for immediate medical attention, supporting market growth.

The customization healthcare services, come with convenience and personalized care, thus attracting elderly patients and leading to the broadening of the market.

Product Code: 12826

Chapter 1. Research Scope

1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by application
- 1.4.2. Market size breakdown, by ownership
- 1.4.3. Market size breakdown, by end user
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
1.5. Market Data Reporting Unit
- 1.5.1. Value
1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes

Chapter 6. Global Market

6.1. Overview
6.2. Market Revenue, by Application (2017-2030)
6.3. Market Revenue, by Ownership (2017-2030)
6.4. Market Revenue, by End User (2017-2030)
6.5. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

7.1. Overview
7.2. Market Revenue, by Application (2017-2030)
7.3. Market Revenue, by Ownership (2017-2030)
7.4. Market Revenue, by End User (2017-2030)
7.5. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

8.1. Overview
8.2. Market Revenue, by Application (2017-2030)
8.3. Market Revenue, by Ownership (2017-2030)
8.4. Market Revenue, by End User (2017-2030)
8.5. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

9.1. Overview
9.2. Market Revenue, by Application (2017-2030)
9.3. Market Revenue, by Ownership (2017-2030)
9.4. Market Revenue, by End User (2017-2030)
9.5. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

10.1. Overview
10.2. Market Revenue, by Application (2017-2030)
10.3. Market Revenue, by Ownership (2017-2030)
10.4. Market Revenue, by End User (2017-2030)
10.5. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

11.1. Overview
11.2. Market Revenue, by Application (2017-2030)
11.3. Market Revenue, by Ownership (2017-2030)
11.4. Market Revenue, by End User (2017-2030)
11.5. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

12.1. Overview
12.2. Market Revenue, by Application (2017-2030)
12.3. Market Revenue, by Ownership (2017-2030)
12.4. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

13.1. Overview
13.2. Market Revenue, by Application (2017-2030)
13.3. Market Revenue, by Ownership (2017-2030)
13.4. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

14.1. Overview
14.2. Market Revenue, by Application (2017-2030)
14.3. Market Revenue, by Ownership (2017-2030)
14.4. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

15.1. Overview
15.2. Market Revenue, by Application (2017-2030)
15.3. Market Revenue, by Ownership (2017-2030)
15.4. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

16.1. Overview
16.2. Market Revenue, by Application (2017-2030)
16.3. Market Revenue, by Ownership (2017-2030)
16.4. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

17.1. Overview
17.2. Market Revenue, by Application (2017-2030)
17.3. Market Revenue, by Ownership (2017-2030)
17.4. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

18.1. Overview
18.2. Market Revenue, by Application (2017-2030)
18.3. Market Revenue, by Ownership (2017-2030)
18.4. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

19.1. Overview
19.2. Market Revenue, by Application (2017-2030)
19.3. Market Revenue, by Ownership (2017-2030)
19.4. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

20.1. Overview
20.2. Market Revenue, by Application (2017-2030)
20.3. Market Revenue, by Ownership (2017-2030)
20.4. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

21.1. Overview
21.2. Market Revenue, by Application (2017-2030)
21.3. Market Revenue, by Ownership (2017-2030)
21.4. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

22.1. Overview
22.2. Market Revenue, by Application (2017-2030)
22.3. Market Revenue, by Ownership (2017-2030)
22.4. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

23.1. Overview
23.2. Market Revenue, by Application (2017-2030)
23.3. Market Revenue, by Ownership (2017-2030)
23.4. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

24.1. Overview
24.2. Market Revenue, by Application (2017-2030)
24.3. Market Revenue, by Ownership (2017-2030)
24.4. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

25.1. Overview
25.2. Market Revenue, by Application (2017-2030)
25.3. Market Revenue, by Ownership (2017-2030)
25.4. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

26.1. Overview
26.2. Market Revenue, by Application (2017-2030)
26.3. Market Revenue, by Ownership (2017-2030)
26.4. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

27.1. Overview
27.2. Market Revenue, by Application (2017-2030)
27.3. Market Revenue, by Ownership (2017-2030)
27.4. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

28.1. Overview
28.2. Market Revenue, by Application (2017-2030)
28.3. Market Revenue, by Ownership (2017-2030)
28.4. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

29.1. List of Market Players and their Offerings
29.2. Competitive Benchmarking of Key Players
29.3. Product Benchmarking of Key Players
29.4. Recent Strategic Developments

Chapter 30. Company Profiles

30.1. Campbell Family Medicine
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
30.2. Castle Connolly Private Health Partners LLC
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
30.3. CONCIERGE CONSULTANTS & CARDIOLOGY
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
30.4. MDVIP LLC
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
30.5. PartnerMD
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
30.6. PENINSULA DOCTOR
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
30.7. Priority Physicians Inc.
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
30.8. SignatureMD Inc.
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
30.9. Specialdocs Consultants LLC
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary

Chapter 31. Appendix

31.1. Abbreviations
31.2. Sources and References
31.3. Related Reports

Concierge Medicine Market Size and Share Analysis by Application (Primary Care, Pediatrics, Osteopathy, Internal Medicine, Cardiology, Psychiatry), Ownership (Independent, Group), End User (Adults, Children) - Global Industry Demand Forecast to 2030